医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML.

广告
第一作者: Aarif M N,Batcha
第一单位: Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.;Data Integration for Future Medicine (DIFUTURE), LMU Munich, Munich, Germany.
作者单位: Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.;Data Integration for Future Medicine (DIFUTURE), LMU Munich, Munich, Germany. [1] Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany. [2] Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.;Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité University Medicine Berlin, Berlin, Germany. [3] Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.;Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany. [4] Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.;Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany. [5] Department of Haematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.;Foundation for the Finnish Cancer Institute, Helsinki, Finland. [6] Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. [7] Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany. [8] Department of Medicine A, Hematology and Oncology, University of Münster, Münster, Germany. [9] German Society of Hematology and Oncology, Berlin, Germany. [10] Department of Medicine III, Hospital Leverkusen, Leverkusen, Germany. [11] Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany. [12] Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.;Data Integration for Future Medicine (DIFUTURE), LMU Munich, Munich, Germany.;German Cancer Consortium, Heidelberg, Germany.;German Cancer Research Center, Heidelberg, Germany. [13] Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.;German Cancer Consortium, Heidelberg, Germany.;German Cancer Research Center, Heidelberg, Germany. [14] Department of Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany. [15]
DOI 10.1182/bloodadvances.2022007988
PMID 36149944
发布时间 2023-03-28
提交
  • 浏览0
Blood advances

Blood advances

2023年7卷6期

1040-1044页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷